NeuroMetrix Reports New Clinical Studies Published on DPNCheck

- January 30th, 2019

NeuroMetrix (Nasdaq:NURO) reported publication of three new DPNCheck clinical studies. DPNCheck is a point-of-care test that provides accurate and cost-effective screening, diagnosis and monitoring of diabetic peripheral neuropathy (DPN). As quoted in the press release: In Kural’s study, 168 patients with type 2 diabetes were evaluated to determine the accuracy of DPNCheck compared to traditional nerve … Continued

NeuroMetrix (Nasdaq:NURO) reported publication of three new DPNCheck clinical studies. DPNCheck is a point-of-care test that provides accurate and cost-effective screening, diagnosis and monitoring of diabetic peripheral neuropathy (DPN).

As quoted in the press release:

In Kural’s study, 168 patients with type 2 diabetes were evaluated to determine the accuracy of DPNCheck compared to traditional nerve conduction studies which are accepted as the gold standard. The authors concluded that DPNCheck is a suitable tool for DPN screening.

In Andersen’s study, DPNCheck was used as the primary outcome measure to assess the prevalence of DPN within an arm of the ADDITION study. The ADDITION study is a large, long term, multi-site study aimed at determining whether intensive treatment of type 2 diabetes reduces macrovascular and microvascular complications. In this 13-year follow-up, 452 participants were tested with DPNCheck. Results showed that higher baseline levels of HbA1c and steeper increase of HbA1c over time were associated with DPN.

In Christensen’s study, 156 young adults with type 1 diabetes were assessed with DPNCheck to examine the prevalence of DPN in this population. The authors determined that DPN has high prevalence in young adults with type 1 diabetes. In addition, the study concluded that screening with novel measurements, such as DPNCheck, may be beneficial for detecting and preventing nerve damage.

Click here to read the full press release.

Are gold stocks a good idea for 2019?


Get your free market forecast today

Leave a Reply

Your email address will not be published. Required fields are marked *